All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation
During the 7th World Congress on Controversies in Multiple Myeloma (COMy), the Multiple Myeloma Hub hosted its first Satellite Symposium: Should 'cure' be the goal for multiple myeloma?
Roundtable discussion—Multiple Myeloma Hub Satellite Symposium: Should 'cure' be the goal for MM?
This video captures the roundtable discussion with Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University (Paris, FR), María-Victoria Mateos, University Hospital of Salamanca (Salamanca, ES), and Sagar Lonial, Winship Cancer Institute of Emory University (Atlanta, US), and includes the concluding remarks of the Satellite Symposium as a whole.
Do we think that the cure vs chronic disease model may be differentially applicable based on genetics? (00:16)
What do you define as acceptable safety profiles for smoldering multiple myeloma (SMM), and where do you set the bar? (04:42)
Does it make a difference to treat SMM patients earlier rather than wait for them to develop IMWG-defined progression? (09:48)
Does immune status/immune function impact the ability to ultimately cure subsets of patients? (13:44)
What do you think of Sagar Lonial's 'siren song' of MRD response? (17:55)
Comment on the curative potential of allogeneic transplant (21:07)
Can you wake the immune senescence with interferon? (22:50)
Final remarks by Sagar Lonial (24:30)
Multiple Myeloma Hub Satellite Symposium: Summary and conclusions
Sagar Lonial's summary and conclusion slides from the first Multiple Myeloma Hub Satellite Symposium are available as a downloadable resource below.Download the slides here!
Find below links to the talks from the symposium:
'Does 'cure' have a different meaning in MM?' presented by Mohamad Mohty.
'Is the treatment of high-risk smoldering multiple myeloma (SMM) the way for achieving the cure?' presented by María-Victoria Mateos.
'Is transplantation still relevant? If yes, in which context?' presented by Sagar Lonial.
'Treating elderly and frail patients with MM: Cure versus disease control' presented by Vincent Rajkumar.
ASH 2019 | Practice-changing abstracts in multiple myeloma
The Multiple Myeloma Hub has developed a downloadable resource, which provides an update on the practice-changing abstracts in multiple myeloma from ASH 2019 in preparation for ASH 2020.
Autologous stem cell transplant in multiple myeloma: optimal regimens
Current status of SCT in MM: this article focuses on the ideal induction, stem-cell mobilization, conditioning, consolidation and maintenance regimens in ASCT.
Subscribe to get the best content related to multiple myeloma delivered to your inbox